[1]
KULKARNI, D. et al. 2026. FORMULATION, CHARACTERIZATION AND PHARMACOKINETIC EVALUATION OF RIVAROXABAN-CITRIC ACID COCRYSTALS WITH ENHANCED SOLUBILITY, STABILITY AND BIOAVAILABILITY. International Journal of Applied Pharmaceutics. 18, 2 (Mar. 2026), 354–368. DOI:https://doi.org/10.22159/ijap.2026v18i2.57537.